# Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery

> **NCT03123068** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 74 (actual)

## Conditions studied

- Surgical Recovery

## Interventions

- **DRUG:** CocoaVia®
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03123068
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-17
- **Primary completion:** 2018-12-14
- **Final completion:** 2018-12-14
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03123068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03123068, "Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03123068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*